Malaria remains a leading cause of morbidity and mortality and is responsible for over 0.5 million annual deaths globally. During the first two decade…

Because of the US cuts to foreign aid, PATH faces a critical funding gap that threatens 30% of our high-stakes health programs. Help us continue this lifesaving work—from vaccinating people against d...

Burkina Faso introduced typhoid conjugate vaccines (TCVs), becoming the first in Francophone Africa to include TCVs in the routine childhood immunization schedule.

PATH current employees - please log in and apply Here PATH is a global nonprofit dedicated to achieving health equity. With more than 40 years of experience forging multisector partnerships and with e...

The World Health Organization has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of relapse of Plasmodium vivax malaria.